← Back to Search

Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy

N/A

Waitlist Available

Led By Kerri Winters-Stone, PhD

Research Sponsored by OHSU Knight Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial studies if whole body vibration can help cancer survivors who have nerve damage from chemotherapy. The treatment involves standing on a vibrating machine to improve movement and reduce pain. The goal is to see if this method is safe and effective for these patients.

Eligible Conditions

Chemotherapy-induced Peripheral Neuropathy
Blood Cancers
Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Accrual

Adherence

Adverse events

+1 more

Secondary study objectives

Body mass index

Pain

Exercise readiness

+11 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Whole body vibration (WBV)Experimental Treatment1 Intervention

Participants assigned to the WBV group will participate in twice daily 10-minute WBV training sessions, 7 days a week. Each WBV session will consist of a series of timed stands on the vibration platform (Marodyne LiV). During a timed stand, participants will perform slow controlled weight shifting exercises and gentle squats. The vibration frequency will be set at 30Hz and the amplitude set at 50-200 microns, for a total body acceleration of 0.4g+/-20%.

Group II: Usual Care (UC)Active Control1 Intervention

Participants randomly assigned to the UC group will serve as controls and will be tested at the same time points as the WBV group. The UC group will be asked not to change their physical activity or dietary habits across the intervention period and we will track any changes using a questionnaire.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Whole Body Vibration

2016

Completed Phase 4

~430

Do I qualify?Apply below to find out